Results 11 to 20 of about 377,127 (288)

Epigenetics and Helicobacter pylori [PDF]

International Journal of Molecular Sciences, 2022
Epigenetics regulates gene expression, cell type development during differentiation, and the cell response to environmental stimuli. To survive, bacteria need to evade the host immune response. Bacteria, including Helicobacter pylori (Hp), reach this target epigenetically, altering the chromatin of the host cells, in addition to several more approaches,
Capparelli R., Iannelli D.
openaire   +3 more sources

Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment

Frontiers in Genetics, 2022
Gastric cancer (GC) is a highly fatal and common malignancy of the digestive system. Recent therapeutic advancements have significantly improved the clinical outcomes in GC, but due to the unavailability of suitable molecular targets, a large number of ...
Fazhan Li, Fazhan Li, Huijuan Wen, Huijuan Wen, Ihtisham Bukhari, Bin Liu, Bin Liu, Chenxu Guo, Chenxu Guo, FeiFei Ren, FeiFei Ren, Youcai Tang, Yang Mi, Yang Mi, Yang Mi, Pengyuan Zheng, Pengyuan Zheng, Pengyuan Zheng   +17 more
doaj   +1 more source

The interplay between Helicobacter pylori and gastrointestinal microbiota

Gut microbes, 2021
The complex population of microbes in the human gastrointestinal (GI) tract interacts with itself and with the host, exerting a deep influence on health and disease development.
Chieh-Chang Chen, Jyh-Ming Liou, Yi-Chia Lee, Tzu-Chan Hong, E. El-Omar, Ming-Shiang Wu   +5 more
semanticscholar   +1 more source

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo, De Francesco, Vincenzo, Bellesia, Annamaria, Vassallo, Roberto, D’angelo, Audenzio, Scaccianoce, Giuseppe, Sacco, Rodolfo, Bresci, Giampaolo, Eramo, Annarita, Tanzilli, Anna, Ridola, Lorenzo, Alvaro, Domenico, Londoni, Claudio, Brambilla, Gianfranco, Manta, Raffaele, Di Ciaula, Agostino, Portincasa, Piero   +16 more
core   +8 more sources

The impact of dioctyl phthalate exposure on multiple organ systems and gut microbiota in mice

Heliyon, 2023
Dioctyl phthalate, commonly known as bis(2-ethylhexyl) phthalate (DEHP), is a widely used plasticizer in various industries and has been shown to directly or indirectly impact human health. However, there is a lack of comprehensive studies evaluating the
Qiang Zhang, Chunjing Qiu, Wenya Jiang, Pengya Feng, Xia Xue, Ihtisham Bukhari, Yang Mi, Pengyuan Zheng   +7 more
doaj   +1 more source

Armeniaspirol A: a novel anti‐Helicobacter pylori agent

Microbial Biotechnology, 2022
Summary Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H.
Jia Jia, Chongwen Zhang, Yaqi Liu, Yanqiang Huang, Yuefan Bai, Xudong Hang, Liping Zeng, Dongqing Zhu, Hongkai Bi   +8 more
doaj   +1 more source

A study on the diagnosis of the Helicobacter pylori coccoid form with artificial intelligence technology

Frontiers in Microbiology, 2022
BackgroundHelicobacter pylori (H. pylori) is an important pathogenic microorganism that causes gastric cancer, peptic ulcers and dyspepsia, and infects more than half of the world’s population. Eradicating H. pylori is the most effective means to prevent
Zishao Zhong, Zishao Zhong, Zishao Zhong, Zishao Zhong, Xin Wang, Xin Wang, Xin Wang, Jianmin Li, Beiping Zhang, Beiping Zhang, Lijuan Yan, Shuchang Xu, Shuchang Xu, Guangxia Chen, Hengjun Gao, Hengjun Gao, Hengjun Gao, Hengjun Gao   +17 more
doaj   +1 more source

Clinical implications of lncRNA LINC-PINT in cancer

Frontiers in Molecular Biosciences, 2023
Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade.
Ihtisham Bukhari, Muhammad Riaz Khan, Fazhan Li, Bartlomiej Swiatczak, Rick Francis Thorne, Pengyuan Zheng, Yang Mi   +6 more
doaj   +1 more source

Bacteriophages of Helicobacter pylori [PDF]

Frontiers in Microbiology, 2020
The bacterium Helicobacter pylori colonize the stomach in approximately half of the world's population. Infection with this bacterium is associated with gastritis, peptic ulcer, adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. Besides being a pathogen with worldwide prevalence, H.
Alba Alicia Trespalacios, Filipa F. Vale, Johanna Stepanian, Angela B Muñoz, Angela B Muñoz   +4 more
openaire   +4 more sources

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice

Frontiers in Nutrition, 2023
Background/aimsSome studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut microbiota may alter bile acid (BAs) composition and kinetics, improving non-alcoholic fatty liver disease (NAFLD ...
Minghua Yang, Minghua Yang, Haoyang Wang, Haoyang Wang, Ihtisham Bukhari, Ye Zhao, Ye Zhao, Huang Huang, Yong Yu, Xiangdong Sun, Yang Mi, Yang Mi, Lu Mei, Pengyuan Zheng, Pengyuan Zheng   +14 more
doaj   +1 more source